---
title: "Top 10 US Stock Gainers (10.31)"
description: "AMTD Digital(HKD) rose 74.56%, with a trading turnover 1.2 Billion USD, and a year-to-date fell 0.3%. Butterfly Network(BFLY) rose 31.86%, with a trading turnover 53.8 Million USD, and a year-to-date "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263812515.md"
published_at: "2025-10-31T22:00:51.000Z"
---

# Top 10 US Stock Gainers (10.31)

> AMTD Digital(HKD) rose 74.56%, with a trading turnover 1.2 Billion USD, and a year-to-date fell 0.3%. Butterfly Network(BFLY) rose 31.86%, with a trading turnover 53.8 Million USD, and a year-to-date fell 13.8%. LexinFintech(LX) rose 25.19%, with a trading turnover 79.4 Million USD, and a year-to-date fell 13%.

NASDAQ Composite Index has rose 0.61%, with a year-to-date rose 22.9%; S&P 500 has rose 0.26%, with a year-to-date rose 16.3%; Dow Jones Industrial Average has rose 0.09%, with a year-to-date rose 11.8%.

AMTD Digital(HKD) rose 74.56%, with a trading turnover 1.2 Billion USD, and a year-to-date fell 0.3%.

Butterfly Network(BFLY) rose 31.86%, with a trading turnover 53.8 Million USD, and a year-to-date fell 13.8%.

LexinFintech(LX) rose 25.19%, with a trading turnover 79.4 Million USD, and a year-to-date fell 13%.

### Related Stocks

- [HKD.US - AMTD Digital](https://longbridge.com/en/quote/HKD.US.md)
- [BFLY.US - Butterfly Network](https://longbridge.com/en/quote/BFLY.US.md)
- [LX.US - LexinFintech](https://longbridge.com/en/quote/LX.US.md)
- [BHF.US - Brighthouse](https://longbridge.com/en/quote/BHF.US.md)
- [ILMN.US - Illumina](https://longbridge.com/en/quote/ILMN.US.md)
- [ARDX.US - Ardelyx](https://longbridge.com/en/quote/ARDX.US.md)
- [PACB.US - Pacific Biosc California](https://longbridge.com/en/quote/PACB.US.md)
- [TWLO.US - Twilio](https://longbridge.com/en/quote/TWLO.US.md)
- [TVTX.US - Travere Therapeutics](https://longbridge.com/en/quote/TVTX.US.md)
- [BJRI.US - BJS Restaurants](https://longbridge.com/en/quote/BJRI.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Travere Therapeutics Q4 Earnings Report: What Investors Need to Know | Travere Therapeutics (NASDAQ:TVTX) reported Q4 earnings on February 19, 2026, beating estimates by 54.17% with an EPS of | [Link](https://longbridge.com/en/news/276377550.md) |
| Travere Therapeutics posts Q4 FILSPARI U.S. net product sales of USD 103.3 million, up 2.08x | Travere Therapeutics reported Q4 2025 net product sales of USD 103.34 million, a 108% increase YoY, contributing to tota | [Link](https://longbridge.com/en/news/276376583.md) |
| Earnings Outlook For Travere Therapeutics | Travere Therapeutics (NASDAQ:TVTX) is set to release its quarterly earnings report on February 19, 2026, with analysts e | [Link](https://longbridge.com/en/news/276254104.md) |
| Travere Therapeutics Chief Legal Officer Elizabeth E. Reed Disposes of Common Shares | Elizabeth E. Reed, Chief Legal Officer of Travere Therapeutics, has disposed of common shares of the company. The full f | [Link](https://longbridge.com/en/news/276378193.md) |
| Insights Ahead: Ardelyx's Quarterly Earnings | Ardelyx (NASDAQ:ARDX) will report its quarterly earnings on February 19, 2026, with analysts estimating an EPS of $0.01. | [Link](https://longbridge.com/en/news/276262655.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.